• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于证据的心房颤动心率控制药物治疗。

Evidenced-based pharmacotherapy for rate control in atrial fibrillation.

作者信息

Greenberg Heather

机构信息

Point Loma Nazarene University, San Diego, California 92040, USA.

出版信息

Crit Care Nurs Q. 2013 Apr-Jun;36(2):237-43. doi: 10.1097/CNQ.0b013e31828415dc.

DOI:10.1097/CNQ.0b013e31828415dc
PMID:23470710
Abstract

Atrial fibrillation is the most common arrhythmia found in older adults that places them at a high risk for stroke. The presence of AF in an individual, especially older than 60 years, increases the risk of mortality, affects quality of life, and increases prevalence of heart failure. The goal of AF treatment is to maintain heart rate or rhythm control and stroke prevention through anticoagulation. With appropriate management of AF an improvement of symptoms and a reduced morbidity from stroke or heart failure can be achieved. The best treatment for AF is prevention and early diagnosis.

摘要

心房颤动是老年人中最常见的心律失常,会使他们面临较高的中风风险。个体出现房颤,尤其是60岁以上的人,会增加死亡风险,影响生活质量,并增加心力衰竭的患病率。房颤治疗的目标是通过抗凝来维持心率或节律控制以及预防中风。通过对房颤进行适当管理,可以改善症状,并降低中风或心力衰竭的发病率。房颤的最佳治疗方法是预防和早期诊断。

相似文献

1
Evidenced-based pharmacotherapy for rate control in atrial fibrillation.基于证据的心房颤动心率控制药物治疗。
Crit Care Nurs Q. 2013 Apr-Jun;36(2):237-43. doi: 10.1097/CNQ.0b013e31828415dc.
2
Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.改善心房颤动患者的结局:预防卒中的心房颤动早期治疗试验的原理和设计。
Am Heart J. 2013 Sep;166(3):442-8. doi: 10.1016/j.ahj.2013.05.015. Epub 2013 Jul 30.
3
Atrial fibrillation: pharmacological therapy.心房颤动:药物治疗。
Curr Probl Cardiol. 2011 Mar;36(3):87-120. doi: 10.1016/j.cpcardiol.2011.01.001.
4
Treatment of atrial fibrillation.心房颤动的治疗。
Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5.
5
Pharmacological treatment of persistent atrial fibrillation in the older adult: evidence-based practice.老年持续性心房颤动的药物治疗:循证实践
J Am Acad Nurse Pract. 2011 Mar;23(3):120-6. doi: 10.1111/j.1745-7599.2010.00593.x. Epub 2011 Feb 10.
6
[Atrial fibrillation in patients with heart failure: treatment and management].[心力衰竭患者的心房颤动:治疗与管理]
Nihon Rinsho. 2013 Jan;71(1):131-5.
7
Treatment of Atrial Fibrillation.心房颤动的治疗。
JAMA. 2015 Jul 21;314(3):278-88. doi: 10.1001/jama.2015.7505.
8
Anticoagulation: stroke prevention in patients with atrial fibrillation.抗凝治疗:心房颤动患者的卒中预防
Cardiol Clin. 2009 Feb;27(1):125-35, ix. doi: 10.1016/j.ccl.2008.09.002.
9
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.影响心房颤动患者抗凝治疗期间出血风险的因素:来自节律管理心房颤动随访调查(AFFIRM)研究的观察结果
Am Heart J. 2005 Apr;149(4):650-6. doi: 10.1016/j.ahj.2004.11.015.
10
Cardiology patient page: stroke prevention in atrial fibrillation.
Circulation. 2012 Apr 24;125(16):e588-90. doi: 10.1161/CIRCULATIONAHA.111.067843.